◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Pola Orbis Holdings Inc. (4927)

Name: Pola Orbis Holdings Inc.（4927）— 財務諸表の推移
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

Consumer Defensive · ウォール街（米国） · 最終更新: 2026-10-02

Pola Orbis Holdings Inc., through its subsidiaries, develops, manufactures, and sells cosmetics and related products in Japan, Asia, and internationally. It operates through Beauty Care, Real Estate, and Others segments. The company offers beauty and health products under the POLA, ORBIS, Jurlique, THREE, DECENCIA, and FUJIMI brand names. It is also involved in the leasing of office buildings in urban areas, as well as management and operation of buildings. Pola Orbis Holdings Inc. was founded in 1929 and is headquartered in Tokyo, Japan.

主要指標

時価総額: JPY 295 billion
売上高（2025-12-31 期末の会計年度）: JPY 170.3B
当期純利益: JPY 9.5B
売上総利益率: 81.2%
純利益率: 5.6%

インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→

年次損益計算書

損益計算書	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
売上高合計	JPY 170.3B	JPY 170.4B	JPY 173.3B	JPY 166.3B	—
売上総利益	JPY 138.3B	JPY 138.5B	JPY 142.1B	JPY 135.3B	—
営業利益（EBIT）	JPY 15.7B	JPY 13.8B	JPY 16.1B	JPY 12.6B	—
当期純利益	JPY 9.5B	JPY 9.3B	JPY 9.7B	JPY 11.4B	—

出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は 4927 のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/4927

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.